Palisade Bio, Inc. Common Stock
PALI •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$1.48
Closed Price
$2.06
Performance
-39.19%
Days Open
14
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 31, 2026
Open Price $1.48
Stop Loss $2.45
Timespan Day
Trade Outcome
Closed Status Loss
Closed Date Apr 14, 2026
Closed Price $2.06
Performance -39.19%
Days Open 14
Company Profile
Name Palisade Bio, Inc. Common Stock
Ticker PALI
Market Cap $3.40M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $2.06
List Date Apr 28, 2021
Description
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Website Open Company Website